News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
750,434 Results
Type
Article (64640)
Company Profile (478)
Press Release (685299)
Multimedia
Podcasts (178)
Webinars (24)
Section
Business (195225)
Career Advice (3431)
Deals (35321)
Drug Delivery (150)
Drug Development (85634)
Employer Resources (189)
FDA (17671)
Job Trends (15288)
News (344562)
Policy (36003)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2963)
Academic (1)
Accelerated approval (35)
Adcomms (36)
Allergies (152)
Alliances (50583)
ALS (182)
Alzheimer's disease (1799)
Antibody-drug conjugate (ADC) (356)
Approvals (17855)
Artificial intelligence (594)
Autoimmune disease (174)
Automation (41)
Bankruptcy (371)
Best Places to Work (11849)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (327)
Bladder cancer (165)
Brain cancer (65)
Breast cancer (673)
Cancer (5103)
Cardiovascular disease (449)
Career advice (2926)
Career pathing (41)
CAR-T (314)
CDC (59)
Celiac Disease (2)
Cell therapy (847)
Cervical cancer (38)
Clinical research (72586)
Collaboration (1857)
Company closure (5)
Compensation (1194)
Complete response letters (75)
COVID-19 (2969)
CRISPR (101)
C-suite (899)
Cystic fibrosis (155)
Data (6384)
Decentralized trials (2)
Denatured (60)
Depression (150)
Diabetes (537)
Diagnostics (6917)
Digital health (51)
Diversity (10)
Diversity, equity & inclusion (47)
Drug discovery (293)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (247)
Earnings (78874)
Editorial (67)
Employer branding (22)
Employer resources (163)
Events (122427)
Executive appointments (1017)
FDA (20898)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1570)
Gene editing (221)
Generative AI (54)
Gene therapy (688)
GLP-1 (1134)
Government (5252)
Grass and pollen (8)
Guidances (382)
Healthcare (19907)
HIV (63)
Huntington's disease (50)
IgA nephropathy (88)
Immunology and inflammation (301)
Immuno-oncology (65)
Indications (111)
Infectious disease (3267)
Inflammatory bowel disease (207)
Inflation Reduction Act (16)
Influenza (126)
Intellectual property (257)
Interviews (665)
IPO (16753)
IRA (61)
Job creations (3816)
Job search strategy (2369)
JPM (70)
Kidney cancer (17)
Labor market (90)
Layoffs (644)
Leadership (40)
Legal (8581)
Liver cancer (99)
Longevity (15)
Lung cancer (688)
Lymphoma (386)
Machine learning (43)
Management (63)
Manufacturing (859)
MASH (177)
Medical device (14220)
Medtech (14275)
Mergers & acquisitions (19670)
Metabolic disorders (1423)
Multiple sclerosis (168)
NASH (23)
Neurodegenerative disease (364)
Neuropsychiatric disorders (104)
Neuroscience (3147)
Neurotech (1)
NextGen: Class of 2026 (7057)
Non-profit (4866)
Now hiring (56)
Obesity (698)
Opinion (333)
Ovarian cancer (171)
Pain (218)
Pancreatic cancer (237)
Parkinson's disease (302)
Partnered (34)
Patents (519)
Patient recruitment (514)
Peanut (61)
People (58954)
Pharmaceutical (87)
Pharmacy benefit managers (33)
Phase 1 (22552)
Phase 2 (31758)
Phase 3 (23978)
Pipeline (5402)
Policy (341)
Postmarket research (2895)
Preclinical (9756)
Press Release (69)
Prostate cancer (253)
Psychedelics (58)
Radiopharmaceuticals (303)
Rare diseases (944)
Real estate (6164)
Recruiting (76)
Regulatory (26937)
Reports (52)
Research institute (2689)
Resumes & cover letters (546)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (162)
Series A (261)
Series B (204)
Service/supplier (12)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (171)
Sponsored (48)
Startups (3749)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (101)
The Weekly (117)
Vaccines (1159)
Venture capital (100)
Weight loss (477)
Women's health (90)
Worklife (22)
Date
Last 7 days (649)
Last 30 days (2147)
Last 365 days (31718)
2026 (3644)
2025 (32173)
2024 (37006)
2023 (41641)
2022 (52833)
2021 (57445)
2020 (55782)
2019 (48568)
2018 (36860)
2017 (34903)
2016 (34814)
2015 (39967)
2014 (33008)
2013 (27889)
2012 (29738)
2011 (29995)
2010 (28001)
Location
Africa (1039)
Alabama (91)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (44576)
Australia (7741)
California (11572)
Canada (3304)
China (1188)
Colorado (483)
Connecticut (505)
Delaware (343)
Europe (103208)
Florida (1727)
Georgia (366)
Hawaii (4)
Idaho (64)
Illinois (922)
India (69)
Indiana (514)
Iowa (24)
Japan (442)
Kansas (129)
Kentucky (42)
Louisiana (28)
Maine (83)
Maryland (1449)
Massachusetts (8546)
Michigan (339)
Minnesota (645)
Mississippi (5)
Missouri (134)
Montana (33)
Nebraska (24)
Nevada (120)
New Hampshire (85)
New Jersey (3127)
New Mexico (33)
New York (3074)
North Carolina (1581)
North Dakota (10)
Northern California (5627)
Ohio (350)
Oklahoma (23)
Oregon (44)
Pennsylvania (2305)
Puerto Rico (24)
Rhode Island (47)
South America (1407)
South Carolina (66)
South Dakota (1)
Southern California (4490)
Tennessee (171)
Texas (1803)
United States (41539)
Utah (340)
Vermont (1)
Virginia (275)
Washington D.C. (85)
Washington State (965)
West Virginia (4)
Wisconsin (128)
Wyoming (1)
750,434 Results for "the parkinson s institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
5 Investigational Therapies That Could Change the Parkinson’s Landscape
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC Immune, Gain Therapeutics and more could shape the future of Parkinson’s disease treatment.
January 26, 2026
·
9 min read
·
Tristan Manalac
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Deals
Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program
Novartis is licensing ARO-SNCA, a preclinical siRNA therapy for synucleinopathies, a group of neurodegenerative disorders including Parkinson’s disease.
September 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
January 29, 2026
·
5 min read
Press Releases
Bexorg Awarded Grant from The Michael J. Fox Foundation to Identify Translational Biomarkers for TRPML1-Targeted Parkinson’s Disease Therapies
January 29, 2026
·
4 min read
Press Releases
Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Parkinson’s Disease
December 23, 2025
·
3 min read
Press Releases
NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial
January 8, 2026
·
4 min read
Press Releases
SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression
January 21, 2026
·
4 min read
Press Releases
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease
January 8, 2026
·
5 min read
Press Releases
Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson’s Disease
January 5, 2026
·
4 min read
1 of 75,044
Next
